Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al
- PMID: 34738307
- PMCID: PMC8646468
- DOI: 10.1111/jth.15578
Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al
Conflict of interest statement
James S. O'Donnell has served on the speaker's bureau for Baxter, Bayer, Novo Nordisk, Sobi, Boehringer Ingelheim, Leo Pharma, Takeda, and Octapharma. He has also served on the advisory boards of Baxter, Sobi, Bayer, Octapharma CSL Behring, Daiichi Sankyo, Boehringer Ingelheim, Takeda, and Pfizer. He has also received research grant funding awards from 3M, Baxter, Bayer, Pfizer, Shire, Takeda, 3M, and Novo Nordisk. The remaining authors have no conflict of interests to declare.
Comment on
-
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al.J Thromb Haemost. 2022 Jan;20(1):267-269. doi: 10.1111/jth.15580. Epub 2021 Nov 22. J Thromb Haemost. 2022. PMID: 34731533 Free PMC article. No abstract available.
Similar articles
-
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al.J Thromb Haemost. 2022 Jan;20(1):267-269. doi: 10.1111/jth.15580. Epub 2021 Nov 22. J Thromb Haemost. 2022. PMID: 34731533 Free PMC article. No abstract available.
-
Persistent endotheliopathy in the pathogenesis of long COVID syndrome.J Thromb Haemost. 2021 Oct;19(10):2546-2553. doi: 10.1111/jth.15490. Epub 2021 Sep 12. J Thromb Haemost. 2021. PMID: 34375505 Free PMC article.
-
COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.Vasc Health Risk Manag. 2021 Jun 1;17:273-298. doi: 10.2147/VHRM.S299357. eCollection 2021. Vasc Health Risk Manag. 2021. PMID: 34103921 Free PMC article. Review.
-
Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction.J Thromb Haemost. 2022 Oct;20(10):2429-2438. doi: 10.1111/jth.15830. Epub 2022 Aug 4. J Thromb Haemost. 2022. PMID: 35875995 Free PMC article.
-
The coagulopathy, endotheliopathy, and vasculitis of COVID-19.Inflamm Res. 2020 Dec;69(12):1181-1189. doi: 10.1007/s00011-020-01401-6. Epub 2020 Sep 12. Inflamm Res. 2020. PMID: 32918567 Free PMC article. Review.
Cited by
-
Long COVID: Molecular Mechanisms and Detection Techniques.Int J Mol Sci. 2023 Dec 28;25(1):408. doi: 10.3390/ijms25010408. Int J Mol Sci. 2023. PMID: 38203577 Free PMC article. Review.
-
von Willebrand factor links primary hemostasis to innate immunity.Nat Commun. 2022 Nov 3;13(1):6320. doi: 10.1038/s41467-022-33796-7. Nat Commun. 2022. PMID: 36329021 Free PMC article.
-
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.J Thromb Thrombolysis. 2021 Nov;52(4):1010-1019. doi: 10.1007/s11239-021-02544-x. Epub 2021 Aug 4. J Thromb Thrombolysis. 2021. PMID: 34350541 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
